依存症治療の世界市場 2023-2027

当レポートでは依存症治療の市場規模は、2023年から2027年の間にCAGR7.65%で98億6000万米ドルの成長を遂げる見込みであると発表しています。当レポートでは、依存症治療市場について、全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。

現在の世界の市場動向と促進要因、市場全体の環境に関する最新の分析を提供しています。

市場は、アルコール、タバコ、オピオイド製品の高い消費量、依存症治療のための新薬の承認やデジタル治療薬の発売、依存症に対する意識の向上と対策に向けた取り組みによって牽引されています。

本調査では、新薬の研究開発の増加が、今後数年間の依存症治療市場の成長を促進する主要な理由の1つであると位置付けています。また、国が運営する無料の依存症治療プログラムや施設の出現、女性のアルコール消費量の増加は、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し：2022-2027年の予測

第4章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第5章 流通チャネル別市場セグメンテーション

• 市場内訳
• 流通チャネル別比較
• 病院薬局 - 市場規模と予測 2022-2027
• 小売薬局 - 市場規模と予測 2022-2027
• その他 - 市場規模と予測 2022-2027
• 流通チャネル別の市場機会

第6章 タイプ別の市場セグメンテーション

• 市場内訳
• タイプ別比較
• アルコール依存症治療 - 市場規模と予測 2022-2027
• タバコ依存症治療 - 市場規模と予測 2022-2027
• 薬物依存症治療 - 市場規模と予測 2022-2027
• タイプ別の市場機会

第7章 顧客情勢

• 顧客情勢の概要

第8章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測 2022-2027
• 欧州 - 市場規模と予測 2022-2027
• アジア - 市場規模と予測 2022-2027
• その他の地域（ROW） - 市場規模と予測 2022-2027
• 米国 - 市場規模と予測 2022-2027
• ドイツ - 市場規模と予測 2022-2027
• カナダ - 市場規模と予測 2022-2027
• 英国 - 市場規模と予測 2022-2027
• フランス - 市場規模と予測 2022-2027
• 地域情勢別の市場機会

第9章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第10章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第11章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Alkermes Public Ltd. Co.
• Amneal Pharmaceuticals Inc.
• Aphios Corp.
• Braeburn Inc.
• Emergent BioSolutions Inc.
• GlaxoSmithKline Plc
• Glenmark Pharmaceuticals Ltd.
• Hikma Pharmaceuticals Plc
• Indivior Plc
• Mallinckrodt Plc
• Orexo AB
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Titan Pharmaceuticals Inc.

第12章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global addictions therapeutics market 2017 - 2021 ($ billion)
• Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
• Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• Exhibits22: Five forces analysis - Comparison between2022 and 2027
• Exhibits23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits25: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits28: Chart on Market condition - Five forces 2022 and 2027
• Exhibits29: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits30: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits31: Chart on Comparison by Distribution Channel
• Exhibits32: Data Table on Comparison by Distribution Channel
• Exhibits33: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibits34: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibits35: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits36: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits37: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibits38: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibits39: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits40: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits41: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibits42: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibits43: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits44: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits45: Market opportunity by Distribution Channel ($ billion)
• Exhibits46: Chart on Type - Market share 2022-2027 (%)
• Exhibits47: Data Table on Type - Market share 2022-2027 (%)
• Exhibits48: Chart on Comparison by Type
• Exhibits49: Data Table on Comparison by Type
• Exhibits50: Chart on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits51: Data Table on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits52: Chart on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits53: Data Table on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits54: Chart on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits55: Data Table on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits56: Chart on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits57: Data Table on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits58: Chart on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits59: Data Table on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits60: Chart on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits61: Data Table on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits62: Market opportunity by Type ($ billion)
• Exhibits63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits64: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits65: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits66: Chart on Geographic comparison
• Exhibits67: Data Table on Geographic comparison
• Exhibits68: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits69: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits70: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits71: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits72: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits73: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits74: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits75: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits76: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits77: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits78: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits79: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits80: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits81: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits82: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits83: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits84: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits85: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits86: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits87: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits88: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits89: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits90: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits91: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits92: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibits93: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibits94: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits95: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits96: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits97: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits98: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits99: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits100: Chart on France - Market size and forecast 2022-2027 ($ billion)
• Exhibits101: Data Table on France - Market size and forecast 2022-2027 ($ billion)
• Exhibits102: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibits103: Data Table on France - Year-over-year growth 2022-2027 (%)
• Exhibits104: Market opportunity By Geographical Landscape ($ billion)
• Exhibits105: Impact of drivers and challenges in 2022 and 2027
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: Alkermes Public Ltd. Co. - Overview
• Exhibits112: Alkermes Public Ltd. Co. - Product / Service
• Exhibits113: Alkermes Public Ltd. Co. - Key news
• Exhibits114: Alkermes Public Ltd. Co. - Key offerings
• Exhibits115: Amneal Pharmaceuticals Inc. - Overview
• Exhibits116: Amneal Pharmaceuticals Inc. - Business segments
• Exhibits117: Amneal Pharmaceuticals Inc. - Key news
• Exhibits118: Amneal Pharmaceuticals Inc. - Key offerings
• Exhibits119: Amneal Pharmaceuticals Inc. - Segment focus
• Exhibits120: Aphios Corp. - Overview
• Exhibits121: Aphios Corp. - Product / Service
• Exhibits122: Aphios Corp. - Key offerings
• Exhibits123: Braeburn Inc. - Overview
• Exhibits124: Braeburn Inc. - Product / Service
• Exhibits125: Braeburn Inc. - Key offerings
• Exhibits126: Emergent BioSolutions Inc. - Overview
• Exhibits127: Emergent BioSolutions Inc. - Product / Service
• Exhibits128: Emergent BioSolutions Inc. - Key news
• Exhibits129: Emergent BioSolutions Inc. - Key offerings
• Exhibits130: GlaxoSmithKline Plc - Overview
• Exhibits131: GlaxoSmithKline Plc - Business segments
• Exhibits132: GlaxoSmithKline Plc - Key offerings
• Exhibits133: GlaxoSmithKline Plc - Segment focus
• Exhibits134: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibits135: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibits136: Glenmark Pharmaceuticals Ltd. - Key offerings
• Exhibits137: Hikma Pharmaceuticals Plc - Overview
• Exhibits138: Hikma Pharmaceuticals Plc - Business segments
• Exhibits139: Hikma Pharmaceuticals Plc - Key offerings
• Exhibits140: Hikma Pharmaceuticals Plc - Segment focus
• Exhibits141: Indivior Plc - Overview
• Exhibits142: Indivior Plc - Product / Service
• Exhibits143: Indivior Plc - Key offerings
• Exhibits144: Mallinckrodt Plc - Overview
• Exhibits145: Mallinckrodt Plc - Business segments
• Exhibits146: Mallinckrodt Plc - Key news
• Exhibits147: Mallinckrodt Plc - Key offerings
• Exhibits148: Mallinckrodt Plc - Segment focus
• Exhibits149: Orexo AB - Overview
• Exhibits150: Orexo AB - Product / Service
• Exhibits151: Orexo AB - Key offerings
• Exhibits152: Otsuka Holdings Co. Ltd. - Overview
• Exhibits153: Otsuka Holdings Co. Ltd. - Business segments
• Exhibits154: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibits155: Otsuka Holdings Co. Ltd. - Segment focus
• Exhibits156: Pfizer Inc. - Overview
• Exhibits157: Pfizer Inc. - Product / Service
• Exhibits158: Pfizer Inc. - Key news
• Exhibits159: Pfizer Inc. - Key offerings
• Exhibits160: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits161: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits162: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits163: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits164: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits165: Titan Pharmaceuticals Inc. - Overview
• Exhibits166: Titan Pharmaceuticals Inc. - Product / Service
• Exhibits167: Titan Pharmaceuticals Inc. - Key offerings
• Exhibits168: Inclusions checklist
• Exhibits169: Exclusions checklist
• Exhibits170: Currency conversion rates for US$
• Exhibits171: Research methodology
• Exhibits172: Validation techniques employed for market sizing
• Exhibits173: Information sources
• Exhibits174: List of abbreviations

Technavio has been monitoring the addictions therapeutics market and it is poised to grow by $9.86 billion during 2023-2027, accelerating at a CAGR of 7.65% during the forecast period. Our report on the addictions therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by high consumption of alcohol, tobacco, and opioid products, approval of new drugs and launch of digital therapeutics to treat addiction, and initiatives to increase awareness about and combat addiction.

The addictions therapeutics market analysis includes the distribution channel and type segments and geographic landscape.

Technavio's addictions therapeutics market is segmented as below:

By Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Others

By Type

• Alcohol addiction therapeutics
• Tobacco addiction therapeutics
• Drug addiction therapeutics

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing R&D of novel drugs as one of the prime reasons driving the addictions therapeutics market growth during the next few years. Also, the emergence of free state-run addiction treatment programs and facilities and increasing alcohol consumption among women will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the addictions therapeutics market covers the following areas:

• Addictions therapeutics market sizing
• Addictions therapeutics market forecast
• Addictions therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading addictions therapeutics market vendors that include Alkermes Public Ltd. Co., Amneal Pharmaceuticals Inc., Aphios Corp., Braeburn Inc., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Indivior Plc, Johnson and Johnson, kaleo Inc., Mallinckrodt Plc, Orexo AB, Otsuka Holdings Co. Ltd., Pfizer Inc., Purdue Pharma LP, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., and Viatris Inc. Also, the addictions therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
• 4.2 Bargaining power of buyers
• Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 4.3 Bargaining power of suppliers
• Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 4.4 Threat of new entrants
• Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027
• 4.5 Threat of substitutes
• Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027
• 4.6 Threat of rivalry
• Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027
• 4.7 Market condition
• Exhibit 24: Chart on Market condition - Five forces 2022 and 2027

5 Market Segmentation by Distribution Channel

• 5.1 Market segments
• Exhibit 25: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 26: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 5.2 Comparison by Distribution Channel
• Exhibit 27: Chart on Comparison by Distribution Channel
• Exhibit 28: Data Table on Comparison by Distribution Channel
• 5.3 Hospital pharmacy - Market size and forecast 2022-2027
• Exhibit 29: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 30: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 31: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 32: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• 5.4 Retail pharmacy - Market size and forecast 2022-2027
• Exhibit 33: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 34: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 36: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• 5.5 Others - Market size and forecast 2022-2027
• Exhibit 37: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 38: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 40: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 5.6 Market opportunity by Distribution Channel
• Exhibit 41: Market opportunity by Distribution Channel ($ billion)

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 42: Chart on Type - Market share 2022-2027 (%)
• Exhibit 43: Data Table on Type - Market share 2022-2027 (%)
• 6.2 Comparison by Type
• Exhibit 44: Chart on Comparison by Type
• Exhibit 45: Data Table on Comparison by Type
• 6.3 Alcohol addiction therapeutics - Market size and forecast 2022-2027
• Exhibit 46: Chart on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 47: Data Table on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 48: Chart on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
• 6.4 Tobacco addiction therapeutics - Market size and forecast 2022-2027
• Exhibit 50: Chart on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 51: Data Table on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Chart on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
• 6.5 Drug addiction therapeutics - Market size and forecast 2022-2027
• Exhibit 54: Chart on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 55: Data Table on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 56: Chart on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 57: Data Table on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
• 6.6 Market opportunity by Type
• Exhibit 58: Market opportunity by Type ($ billion)

7 Customer Landscape

• 7.1 Customer landscape overview
• Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
• Exhibit 60: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 61: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 8.2 Geographic comparison
• Exhibit 62: Chart on Geographic comparison
• Exhibit 63: Data Table on Geographic comparison
• 8.3 North America - Market size and forecast 2022-2027
• Exhibit 64: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 65: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 66: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 8.4 Europe - Market size and forecast 2022-2027
• Exhibit 68: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 69: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 70: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 8.5 Asia - Market size and forecast 2022-2027
• Exhibit 72: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 73: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 74: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 75: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 8.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 76: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 77: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 78: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 79: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 8.7 US - Market size and forecast 2022-2027
• Exhibit 80: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 81: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 82: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 83: Data Table on US - Year-over-year growth 2022-2027 (%)
• 8.8 Germany - Market size and forecast 2022-2027
• Exhibit 84: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 85: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 86: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 87: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 8.9 Canada - Market size and forecast 2022-2027
• Exhibit 88: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 89: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 90: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 91: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 8.10 UK - Market size and forecast 2022-2027
• Exhibit 92: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 93: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 94: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 95: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 8.11 France - Market size and forecast 2022-2027
• Exhibit 96: Chart on France - Market size and forecast 2022-2027 ($ billion)
• Exhibit 97: Data Table on France - Market size and forecast 2022-2027 ($ billion)
• Exhibit 98: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 99: Data Table on France - Year-over-year growth 2022-2027 (%)
• 8.12 Market opportunity By Geographical Landscape
• Exhibit 100: Market opportunity By Geographical Landscape ($ billion)

9 Drivers, Challenges, and Trends

• 9.1 Market drivers
• 9.2 Market challenges
• 9.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2022 and 2027
• 9.4 Market trends

10 Vendor Landscape

• 10.1 Overview
• 10.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 10.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 10.4 Industry risks
• Exhibit 104: Impact of key risks on business

11 Vendor Analysis

• 11.1 Vendors covered
• Exhibit 105: Vendors covered
• 11.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 11.3 Alkermes Public Ltd. Co.
• Exhibit 107: Alkermes Public Ltd. Co. - Overview
• Exhibit 108: Alkermes Public Ltd. Co. - Product / Service
• Exhibit 109: Alkermes Public Ltd. Co. - Key news
• Exhibit 110: Alkermes Public Ltd. Co. - Key offerings
• 11.4 Amneal Pharmaceuticals Inc.
• Exhibit 111: Amneal Pharmaceuticals Inc. - Overview
• Exhibit 112: Amneal Pharmaceuticals Inc. - Business segments
• Exhibit 113: Amneal Pharmaceuticals Inc. - Key news
• Exhibit 114: Amneal Pharmaceuticals Inc. - Key offerings
• Exhibit 115: Amneal Pharmaceuticals Inc. - Segment focus
• 11.5 Aphios Corp.
• Exhibit 116: Aphios Corp. - Overview
• Exhibit 117: Aphios Corp. - Product / Service
• Exhibit 118: Aphios Corp. - Key offerings
• 11.6 Braeburn Inc.
• Exhibit 119: Braeburn Inc. - Overview
• Exhibit 120: Braeburn Inc. - Product / Service
• Exhibit 121: Braeburn Inc. - Key offerings
• 11.7 Emergent BioSolutions Inc.
• Exhibit 122: Emergent BioSolutions Inc. - Overview
• Exhibit 123: Emergent BioSolutions Inc. - Product / Service
• Exhibit 124: Emergent BioSolutions Inc. - Key news
• Exhibit 125: Emergent BioSolutions Inc. - Key offerings
• 11.8 GlaxoSmithKline Plc
• Exhibit 126: GlaxoSmithKline Plc - Overview
• Exhibit 127: GlaxoSmithKline Plc - Business segments
• Exhibit 128: GlaxoSmithKline Plc - Key offerings
• Exhibit 129: GlaxoSmithKline Plc - Segment focus
• 11.9 Glenmark Pharmaceuticals Ltd.
• Exhibit 130: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibit 131: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibit 132: Glenmark Pharmaceuticals Ltd. - Key offerings
• 11.10 Hikma Pharmaceuticals Plc
• Exhibit 133: Hikma Pharmaceuticals Plc - Overview
• Exhibit 134: Hikma Pharmaceuticals Plc - Business segments
• Exhibit 135: Hikma Pharmaceuticals Plc - Key offerings
• Exhibit 136: Hikma Pharmaceuticals Plc - Segment focus
• 11.11 Indivior Plc
• Exhibit 137: Indivior Plc - Overview
• Exhibit 138: Indivior Plc - Product / Service
• Exhibit 139: Indivior Plc - Key offerings
• 11.12 Mallinckrodt Plc
• Exhibit 140: Mallinckrodt Plc - Overview
• Exhibit 141: Mallinckrodt Plc - Business segments
• Exhibit 142: Mallinckrodt Plc - Key news
• Exhibit 143: Mallinckrodt Plc - Key offerings
• Exhibit 144: Mallinckrodt Plc - Segment focus
• 11.13 Orexo AB
• Exhibit 145: Orexo AB - Overview
• Exhibit 146: Orexo AB - Product / Service
• Exhibit 147: Orexo AB - Key offerings
• 11.14 Otsuka Holdings Co. Ltd.
• Exhibit 148: Otsuka Holdings Co. Ltd. - Overview
• Exhibit 149: Otsuka Holdings Co. Ltd. - Business segments
• Exhibit 150: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibit 151: Otsuka Holdings Co. Ltd. - Segment focus
• 11.15 Pfizer Inc.
• Exhibit 152: Pfizer Inc. - Overview
• Exhibit 153: Pfizer Inc. - Product / Service
• Exhibit 154: Pfizer Inc. - Key news
• Exhibit 155: Pfizer Inc. - Key offerings
• 11.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus
• 11.17 Titan Pharmaceuticals Inc.
• Exhibit 161: Titan Pharmaceuticals Inc. - Overview
• Exhibit 162: Titan Pharmaceuticals Inc. - Product / Service
• Exhibit 163: Titan Pharmaceuticals Inc. - Key offerings

12 Appendix

• 12.1 Scope of the report
• 12.2 Inclusions and exclusions checklist
• Exhibit 164: Inclusions checklist
• Exhibit 165: Exclusions checklist
• 12.3 Currency conversion rates for US$
• Exhibit 166: Currency conversion rates for US$
• 12.4 Research methodology
• Exhibit 167: Research methodology
• Exhibit 168: Validation techniques employed for market sizing
• Exhibit 169: Information sources
• 12.5 List of abbreviations
• Exhibit 170: List of abbreviations
  • health: Includes veterinary drugs (excluded from the scope of the report)